BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24748278)

  • 1. Comparative study on pharmacokinetics of a series of anticholinergics, atropine, anisodamine, anisodine, scopolamine and tiotropium in rats.
    Tian F; Li C; Wang X; Ren S; Li N; Liu Q; Zhou S; Lu Y; Zhao D; Chen X
    Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):245-53. PubMed ID: 24748278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of atropine, scopolamine, and anisodamine from Hyoscyamus niger L. in rat plasma by high-performance liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetics study.
    Zhang P; Li Y; Liu G; Sun X; Zhou Y; Deng X; Liao Q; Xie Z
    J Sep Sci; 2014 Oct; 37(19):2664-74. PubMed ID: 25044356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning deficits induced by 4 belladonna alkaloids are preferentially attenuated by tacrine.
    Pan SY; Han YF
    Acta Pharmacol Sin; 2000 Feb; 21(2):124-30. PubMed ID: 11263258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Belladonna alkaloids-induced behavioral changes and amnesia on open-field and step-through in 18-, 28-, and 38-day-old mice.
    Pan SY; Han YF; Xu QP; Liu MY; Ma HZ; Ding WJ; Zhu RL
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):112-6. PubMed ID: 10374631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and tissue distribution of the anticholinergics tiotropium and ipratropium in the rat and dog.
    Leusch A; Eichhorn B; Müller G; Rominger KL
    Biopharm Drug Dispos; 2001 Jul; 22(5):199-212. PubMed ID: 11745922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenoceptor blocking properties of atropine-like agents anisodamine and anisodine on brain and cardiovascular tissues of rats.
    Varma DR; Yue TL
    Br J Pharmacol; 1986 Mar; 87(3):587-94. PubMed ID: 2879586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological properties of tiotropium.
    Barnes PJ
    Chest; 2000 Feb; 117(2 Suppl):63S-6S. PubMed ID: 10673478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease.
    van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ
    Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral analysis of heart rate variability as a quantitative measure of parasympatholytic effect--integrated pharmacokinetics and pharmacodynamics of three anticholinergic drugs.
    Scheinin H; Helminen A; Huhtala S; Grönroos P; Bosch JA; Kuusela T; Kanto J; Kaila T
    Ther Drug Monit; 1999 Apr; 21(2):141-51. PubMed ID: 10217331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease.
    Hohlfeld JM; Sharma A; van Noord JA; Cornelissen PJ; Derom E; Towse L; Peterkin V; Disse B
    J Clin Pharmacol; 2014 Apr; 54(4):405-14. PubMed ID: 24165906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium: an inhaled anticholinergic for chronic obstructive pulmonary disease.
    Olin JL
    Am J Health Syst Pharm; 2005 Jun; 62(12):1263-9. PubMed ID: 15947126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Central effects of anisodamine, atropine, anisodine and scopolamine after intraventricular injection].
    Peng JZ; Jin LR; Chen XY; Chen ZX
    Zhongguo Yao Li Xue Bao; 1983 Jun; 4(2):81-7. PubMed ID: 6225308
    [No Abstract]   [Full Text] [Related]  

  • 14. Tiotropium bromide.
    Barnes PJ
    Expert Opin Investig Drugs; 2001 Apr; 10(4):733-40. PubMed ID: 11281822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
    Renner UD; Oertel R; Kirch W
    Ther Drug Monit; 2005 Oct; 27(5):655-65. PubMed ID: 16175141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
    Salpeter SR
    Drugs; 2009 Oct; 69(15):2025-33. PubMed ID: 19791824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate.
    Ogoda M; Niiya R; Koshika T; Yamada S
    J Pharmacol Sci; 2011; 115(3):374-82. PubMed ID: 21358117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of anticholinergics in chronic obstructive pulmonary disease.
    Barnes PJ
    Am J Med; 2004 Dec; 117 Suppl 12A():24S-32S. PubMed ID: 15693640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disordering effect of hyoscyamine drugs on phospholipid membranes.
    Hwang F; Wang SM; Hu CC
    Biochim Biophys Acta; 1983 Dec; 736(2):220-5. PubMed ID: 6317032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative physiology and efficacy of atropine and scopolamine in sarin nerve agent poisoning.
    Cornelissen AS; Klaassen SD; van Groningen T; Bohnert S; Joosen MJA
    Toxicol Appl Pharmacol; 2020 Jun; 396():114994. PubMed ID: 32251685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.